Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1. | Zeggini, E;...; Herder, C;...; Meisinger, C;...; Altshuler, D | Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. NAture Genetics. 40(5): 638-45 (MAY 2008) | 965 |
2. | Willer, CJ;...; Hebebrand, J;...; Hirschhorn, JN | Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. NAture Genetics. 41(1): 25-34 (JAN 2009) | 743 |
3. | Speliotes, EK;...; Hinney, A;...; Kovacs, P;...; Wallaschofski, H;...; Hebebrand, J;...; Stumvoll, M;...; Peters, A;...; Reinehr, T;...; Wabitsch, M;...; Loos, RJF | Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. NAture Genetics. 42(11): 937-U53 (NOV 2010) | 724 |
4. | Loos, RJF;...; Hebebrand, J;...; Hinney, A;...; Wareham, NJ | Common variants near MC4R are associated with fat mass, weight and risk of obesity. NAture Genetics. 40(6): 768-75 (JUN 2008) | 625 |
5. | Inzucchi, SE;...; Nauck, MA;...; Matthews, DR | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. DIABETES CARE 35 (6): 1364-79 (JUN 2012) | 617 |
6. | Voight, BF;...; Herder, C;...; Rathmann, W;...; Roden, M;...; McCarthy, MI | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. NAture Genetics. 42(7): 579-U155 (JUL 2010) | 616 |
7. | Dupuis, J;...; Herder, C;...; Kovacs, P;...; Meisinger, C;...; Rathmann, W;...; Roden, M;...; Spranger, J;...; Stumvoll, M;...; Barroso, I | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics. 42(2): 105-U32 (FEB 2010) | 614 |
8. | Yao, JC;...; Pavel, ME;...; Oberg, K | Everolimus for Advanced Pancreatic Neuroendocrine Tumors. NEW ENGL. J. MED. 364(6): 51-23 (FEB 10 2011) | 597 |
9. | Dobnig, H; Pilz, S;...; Böhm, BO; Weihrauch, G;...; März, W | Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. ARCH. INTERN. MED. 168(12): 1340-9 (JUN 23 2008) | 544 |
10. | Tonino, PAL; De Bruyne, B;...; Klauss, V;...; Fearon, WF | Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. LANCET 373 (9681): 2125-2135 (JUN 20 2009) | 439 |